NEW CONDENSED HETEROARYLDIHYDROPYRIMIDINES IN POSITION 6 FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION

MA39721AUndetermined Publication Date: 2017-01-11F HOFFMANN LA ROCHE & CO AG

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: MA39721
Authority / Receiving Office: MA · MA
Patent Type: Applications
Current Assignee / Owner
Priority Date: 2015-01-16
Filing Date: 2015-03-04
Publication Date: 2017-01-11

Application Information

Patent Timeline

16 Jan 2015

Priority

04 Mar 2015

Application

MA39721

11 Jan 2017

Publication

MA39721A

IPC: A61K31/4985; A61P31/12; C07D487/04; C07D498/04; C07D513/04

CPC: C07D471/04; C07D487/04; C07D498/04; C07D513/04; A61K31/4985; A61K31/517; A61K31/519; A61P31/00

Inventors: ZHU Wei; GUO Lei

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

The invention relates to new compounds corresponding to the general formula (i), in which r 1 , r 2 , r 3 , r 4 , r 5 , r 6 x, y, w, and n are as described in the description, on compositions comprising these compounds and on methods of using these compounds. These compounds are useful for therapy and / or prophylaxis in humans. In particular, the invention relates to hepatitis b virus (HBV) inhibitors targeting the HBV capsid to treat HBV infection.

Need to check novelty before this filing date? Find Prior Art